Bean rust
Phakopsora meibomiae
Description
Phakopsora meibomiae is a fungal pathogen responsible for a condition known as bean rust. It belongs to the order Pucciniales and is recognized as an obligate parasite of leguminous plants. While often overshadowed by other rust species, this pathogen remains a significant concern for bean production in warm and humid regions, capable of causing localized but severe outbreaks.
The primary hosts of this fungus are common beans (Phaseolus vulgaris) and several other species within the Fabaceae family. The pathogen predominantly attacks the foliage, including the leaves and petioles. By invading plant tissues, the fungus disrupts essential physiological processes such as transpiration and photosynthesis, directly impacting the plant's health and development.
Initial symptoms manifest as small, light-colored flecks on the leaf surface. As the fungus matures, these flecks develop into raised pustules containing urediniospores. These structures eventually rupture, releasing masses of reddish-brown or rust-colored spores that cover the foliage. Over time, the affected leaves become yellow, wither, and drop prematurely, which significantly reduces the leaf area available for grain filling.
Environmental conditions play a crucial role in the development of bean rust. The fungus thrives in high humidity, prolonged dew, and temperatures ranging from 18°C to 25°C. These conditions are optimal for spore germination and infection of the host tissue. Once the infection is established, the wind acts as the primary vector for spreading the disease across neighboring fields, potentially leading to rapid epidemics.
Economic damage caused by the pathogen can be substantial, often resulting in diminished seed quality and reduced overall yield. Effective management strategies include the implementation of cultural practices such as crop rotation and the removal of infected debris. Furthermore, farmers are advised to use resistant cultivars and apply targeted fungicides, such as triazoles or strobilurins, at the onset of symptoms to mitigate the impact of the disease.
Products · 0
Discussion
No discussions yet — be the first.